Zhang, Yi
Kang, Guangbo
Yuan, Haibin
Feng, Zelin
Huang, He
Gao, Feng
Funding for this research was provided by:
National Natural Science Foundation of China (32270692)
Article History
Received: 27 November 2025
Accepted: 30 April 2026
First Online: 11 May 2026
Declarations
Competing interests: The authors declare no competing interests.
Ethics approval and consent to participate: The human pancreatic ductal adenocarcinoma cell line, BxPC-3 (RRID: CVCL_0186) was obtained from the Cell Culture Center, Peking Union Medical College (Beijing, China). MIA PaCa-2 (RRID: CVCL_0428), HPAF-Ⅱ (RRID: CVCL_0313), CFPAC-1 (RRID: CVCL_1119), SW1990 (RRID: CVCL_1723) were obtained from the American Type Culture Collection (Manassas, VA, USA).